Treatment Heterogeneity in Asthma: Genetics of Response to Leukotriene Modifiers

Author： Lima John J.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.11, Iss.2, 2007-01, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Position of Pranlukast, a Cysteinyl Leukotriene Receptor Antagonist, in the Long-Term Treatment of Asthma

By  

Respiration, Vol. 71, Iss. 3, 2004-05 ,pp. : 225-232

Karger

Access to resources Recommend Favorite

Monitoring Asthma Severity and Response to Treatment

By  

Respiration, Vol. 68, Iss. 6, 2001-12 ,pp. : 637-648

Karger

Access to resources Recommend Favorite

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses

By Tyson Darren R   Quaranta Vito  

Personalized Medicine, Vol. 10, Iss. 3, 2013-05 ,pp. : 221-225

Future Medicine

Access to resources Recommend Favorite

Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?

By Alic L   van Vliet M   van Dijke C F   Eggermont A M M   Veenland J F   Niessen W J  

Physics in Medicine and Biology, Vol. 56, Iss. 6, 2011-03 ,pp. : 1601-1616

IOP Publishing

Access to resources Recommend Favorite

Biologic Response Modifiers and Pediatric Psoriasis

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 3, 2015-05 ,pp. : 303-320

John Wiley & Sons Inc

Access to resources Recommend Favorite